KRMD שולי רווח נקי ממכירות KORU Medical

KORU Medical Systems (KRMD) current net profit margin demonstrates profitability dynamics, where the current value equals -1.80. Revenue growth is based on the sale of consumables for home infusions, which create a recurring payment stream. Stability is ensured by dominance in the subcutaneous immunoglobulin administration segment. High barriers to entry are maintained by patents and FDA certification, which prevents patients from switching to other medical systems.
פילוחי נתונים אנליטיים מרוכזים עבור KORU Medical (KRMD)

The aggressive expansion of KORU Medical Systems and the scaling of Freedom pump sales require strict control of operating expenses to ensure profitability. An analysis of net profit margin reveals hidden cost growth alongside increasing revenue, demonstrating the actual share of bottom-line profit in every dollar of sales and confirming the fundamental capital stability of the issuer.